发明授权
US09155780B2 Short beta-defensin-derived peptides 有权
短的β-防御素衍生肽

Short beta-defensin-derived peptides
摘要:
The invention is directed to beta-defensin-derived peptides and their use in modulating the activity of hematopoietic cells and other CXCR4-expressing cells. Specifically, the invention provides compositions and methods useful in the treatment of cancer. The invention further provides compositions and methods useful for promoting mobilization and transplantation of hematopoietic stem cells and progenitor cells.
公开/授权文献
信息查询
0/0